Buy Versartis Stock | VSAR Stock Price & Latest News | Public.com
VSAR

Versartis

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Versartis (VSAR) stock trends here

    About VSAR

    Aravive, Inc. operates as a clinical stage biotechnology company. The firm engages in the development of new therapies that target important survival pathways for both advanced solid tumors as well as hematologic malignancies. Its product candidate, Aravive-S6, is a sol...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$100,06M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$14.94
    1 Year Low$4.27
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app